Multiple osteochondromas

por Bovée, Judith VMG
Publicado 2008

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm

por Bovée, Judith VMG, Hogendoorn, Pancras CW
Publicado 2019

Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013

por van Maldegem, Annemiek M, Bovée, Judith VMG, Gelderblom, Hans
Publicado 2014

Multiple Osteochondromas: Clinicopathological and Genetic Spectrum and Suggestions for Clinical Management

por Hameetman, Liesbeth, Bovée, Judith VMG, Taminiau, Antonie HM, Kroon, Herman M, Hogendoorn, Pancras CW
Publicado 2004

Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples

por de Jong, Danielle, Verbeke, Sofie LJ, Meijer, Danielle, Hogendoorn, Pancras CW, Bovee, Judith VMG, Szuhai, Károly
Publicado 2011

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo

por Meijer, Danielle, Gelderblom, Hans, Karperien, Marcel, Cleton-Jansen, Anne-Marie, Hogendoorn, Pancras CW, Bovée, Judith VMG
Publicado 2011

The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo

por Suijker, Johnny, Baelde, Hans J., Roelofs, Helene, Cleton-Jansen, Anne-Marie, Bovée, Judith V.M.G.
Publicado 2015

Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas

por Kleiburg, Fleur, Heijmen, Linda, Gelderblom, Hans, Kielbasa, Szymon M, Bovée, Judith VMG, De Geus-Oei, Lioe-Fee
Publicado 2023

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option

por Willems, Stefan M, Schrage, Yvonne M, Bruijn, Inge H Briaire-de, Szuhai, Karoly, Hogendoorn, Pancras CW, Bovée, Judith VMG
Publicado 2010

BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors

por Boeuf, Stephane, Bovée, Judith VMG, Lehner, Burkhard, van den Akker, Brendy, van Ruler, Maayke, Cleton-Jansen, Anne-Marie, Richter, Wiltrud
Publicado 2012

Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy

por de Groot, Stefanie, Gelderblom, Hans, Fiocco, Marta, Bovée, Judith VMG, van der Hoeven, Jacobus JM, Pijl, Hanno, Kroep, Judith R
Publicado 2017

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway

por Addie, Ruben D., de Jong, Yvonne, Alberti, Gaia, Kruisselbrink, Alwine B., Que, Ivo, Baelde, Hans, Bovée, Judith V.M.G.
Publicado 2019

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro

por Schrage, Yvonne M, Lam, Suzanne, Jochemsen, Aart G, Cleton-Jansen, Anne-Marie, Taminiau, Antonie HM, Hogendoorn, Pancras CW, Bovée, Judith VMG
Publicado 2009

Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeutics

por Ratcliffe, Peter, Koivunen, Peppi, Myllyharju, Johanna, Ragoussis, Jiannis, Bovée, Judith VMG, Batinic-Haberle, Ines, Vinatier, Claire, Trichet, Valérie, Robriquet, Florence, Oliver, Lisa, Gardie, Betty
Publicado 2017

Genome-wide analysis of Ollier disease: Is it all in the genes?

por Pansuriya, Twinkal C, Oosting, Jan, Krenács, Tibor, Taminiau, Antonie HM, Verdegaal, Suzan HM, Sangiorgi, Luca, Sciot, Raf, Hogendoorn, Pancras CW, Szuhai, Karoly, Bovée, Judith VMG
Publicado 2011

Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma

por Verschoor, Arie Jan, Speetjens, Frank M., Dijkstra, P.D. Sander, Fiocco, Marta, van de Sande, Michiel A.J., Bovée, Judith V.M.G., Gelderblom, Hans
Publicado 2019

Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status

por Venneker, Sanne, Kruisselbrink, Alwine B., Briaire-de Bruijn, Inge H., de Jong, Yvonne, van Wijnen, Andre J., Danen, Erik H.J., Bovée, Judith V.M.G.
Publicado 2019

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy

por Luk, Sietse J, van der Steen, Dirk M, Hagedoorn, Renate S, Jordanova, Ekaterina S, Schilham, Marco W, Bovée, Judith VMG, Cleven, Arjen HG, Falkenburg, JH Frederik, Szuhai, Karoly, Heemskerk, Mirjam HM
Publicado 2018

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone

por van Oosterwijk, Jolieke G, de Jong, Danielle, van Ruler, Maayke AJH, Hogendoorn, Pancras CW, Dijkstra, PD Sander, van Rijswijk, Carla SP, Machado, Isidro, Llombart-Bosch, Antonio, Szuhai, Karoly, Bovée, Judith VMG
Publicado 2012

Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features

por Mertens, Fredrik, Romeo, Salvatore, Bovée, Judith VMG, Tirabosco, Roberto, Athanasou, Nick, Alberghini, Marco, Hogendoorn, Pancras CW, Dei Tos, Angelo P, Sciot, Raf, Domanski, Henryk A, Åström, Kristina, Mandahl, Nils, Debiec-Rychter, Maria
Publicado 2011